Suffering from coronary heart disease, angina pectoris occurs from time to time, is it okay to take

Angina pectoris is episodic chest pain or discomfort caused by acute temporary ischemia or hypoxia of the heart muscle, often during physical activity or emotional agitation. Tongxinluo capsule can dilate coronary arteries, relieve vasospasm, improve blood supply to the myocardium, and thus improve the symptoms of angina. Tongxinluo capsule can also prevent plaque formation, stabilize plaques that have formed, prevent plaque rupture, and reduce the occurrence of myocardial infarction.

It can be seen that taking Tongxinluo Capsule can not only improve angina symptoms, but also prevent the progression of coronary heart disease.

Patients with angina pectoris can take Tongxinluo capsules, which is a type of coronary heart disease in cardiology, which is mostly complicated by hypertension, diabetes, and hyperlipidemia patients. The first of this disease is to dilate the coronary arteries, promote blood circulation and remove blood stasis, improve arteriosclerosis, and stabilize plaques. If the situation is not relieved after taking Tongxinluo capsules, it is recommended that you go to the hospital in time and the cardiology department should be treated in time.

Tongxinluo capsule Chinese patent medicine, with the effect of blood circulation and blood stasis, can stabilize angina, for unstable angina is not recommended to use alone.

I remember describing that you have coronary heart disease, sometimes angina, whether you can eat or not to eat Tongxinluo capsules, this is not easy to say here? You should go to a regular hospital for a comprehensive examination and let the doctor give you a reasonable plan, so that you can prescribe the right medicine in time, so that you can get the disease in time, in order to achieve the disease, in addition to finally as soon as possible.

You can eat it. This product is used for coronary heart disease angina pectoris, which is a deficiency of heart qi and blood stasis obstruction, and the symptoms are chest tightness, tingling, colic, immobility, palpitations, sweating, shortness of breath and fatigue, purple and dark tongue or ecchymosis, thin pulse or contagion.

My mother had angina pectoris before, she was a poor heart droop reflux, she would have heartache and insomnia if she was tired and rested badly, I prescribed Chinese medicine to him in the hospital last year, and I felt comfortable after eating it for a week, and now I have been eating it for half a year, and I have not **. Now I usually pay attention to my diet, but I don't overwork.

Coronary arteries are present.

When blocked, you can use Tongxinluo capsules**. The arteries and blood vessels of our body are a large system, atherosclerosis.

Plaque formation does not occur in just one place. This time it was blocked here, and next time it may be blocked elsewhere. It is still necessary to take medication for **.

In recent years, studies have confirmed that Tongxinluo Capsule has a good efficacy and unique advantages in preventing atherosclerosis. Tongxinluo Capsule can not only protect the vascular endothelium from the damage of factors such as the "three highs", but also repair the damaged vascular endothelium, so that there is no environment for plaque to form. Tongxinluo capsule can also regulate blood lipids and reduce platelets.

agglutination, eliminating the "culprit" of plaque formation. For the plaques that have formed, Tongxinluo Capsule can stabilize the plaque by increasing the thickness of the plaque capsule and reducing the lipids in the plaque, and can also inhibit vasospasm, prevent plaque rupture, and reduce myocardial infarction.

Acute events such as cerebral infarction occur.

Even patients who plan to have a stent or thrombolysis, or who have had a stent or thrombolysis after stenting, can also take Tongxinluo capsules. Tongxinluo capsule can reduce the incidence of "no reflow of myocardium after reperfusion" and "reperfusion injury" after surgery, and reduce the incidence of myocardial infarction.

There are two main ways to block coronary arteries in the heart:

1.Drugs**.

Drugs are the most commonly used method for clogged coronary arteries in the heart. The main drugs are anticoagulant drugs, thrombolytic drugs, and drugs that dilate the blood vessels of the heart. According to the severity of coronary artery blockage, the appropriate drug can be reasonably selected.

Some mild coronary artery blockages may be relieved with medications**. Medications are also commonly used to maintain coronary arteries for a long time.

2.Surgery**.

Surgery is a common method for more severe coronary artery blockages. After coronary artery blockage, surgery can be performed immediately, such as cardiac coronary artery stenting, arterial vascular bypass surgery, etc. It is necessary to choose the appropriate method according to the location and severity of the specific embolized blood vessels**.

Cardiac stenting is the most commonly used method of surgery** for clogged coronary arteries in the heart.

Coronary artery blockage is a serious lesion that can be life-threatening, so it is important to have a check-up immediately after it occurs. And choose the appropriate method according to the characteristics of the lesion**.

Tongxinluo Capsule is a kind of Chinese patent medicine, which has the effect of invigorating qi and invigorating blood, and relieving pain, and the effect is relatively good for patients with chest tightness, chest pain, palpitations or shortness of breath.

However, Tongxinluo capsule can only be used as an adjunct, patients with coronary heart disease are recommended to be on the basis of need, can be combined with traditional Chinese medicine ** effect will be better, coronary heart disease patients commonly used Western drugs include aspirin, clopidogrel, atorvastatin, isosorbide mononitrate, etc.

Coronary heart disease is due to coronary atherosclerotic lesions caused by the narrowing of the lumen of the blood vessels, which causes ischemia and hypoxia of the myocardium, the high incidence of coronary heart disease is the elderly patients, the incidence of coronary heart disease is gradually tending to be younger, the continuous improvement of the main living standards and bad living habits have a certain relationship.

These two drugs belong to the first cardiovascular and cerebrovascular Chinese patent medicines, and the effects should be basically similar. Most of them belong to drugs that promote blood circulation and remove blood stasis. It is recommended to take only one type of service.

Patients with coronary heart disease should pay attention to rest on time, avoid fatigue and mental tension, maintain emotional stability, eat a low-salt and low-fat diet, and go to the hospital for follow-up if necessary.

The objective of this study was to observe the effect of Tongxinluo Capsule on the levels of plasma matrix metalloproteinase-2 9 (MMP-2 9) in patients with unstable angina pectoris (UAP), and to preliminarily investigate the possible mechanism of action of UAP. MethodsA prospective study was used. A total of 110 UAP patients admitted to our hospital from February 2010 to June 2011 were randomly divided into Tongxinluo group (58 cases) and conventional group (52 cases) according to the random number table method.

The conventional group was given aspirin, simvastatin, nitrates; In the Tongxinluo group, 3 capsules (0 26g capsules) were added to the regular group drug**, 3 times a day. During the same period, 100 age-matched healthy patients in our hospital were selected as healthy controls. Enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of MMP-2 9 before and after ** month.

ResultsThe level of MMP-2 9 (G L) in UAP patients was significantly higher than that in healthy control groups (MMP-2: 448 09 11 90 vs. 215 56 14: 624 94 12 12 vs. 384 41 21 74, all P 0 01).

The concentration of MMP-2 9 in the Tongxinluo group was similar to that in the conventional group** (MMP-2: 450 32 11 20 vs. 445 96 12 26, MMP-9: 625 92 13 17 vs. 623 99 11 07, both P 0 05); With the extension of **time, the level of MMP-2 9 after the two groups was significantly lower than that in the previous time point of the group (P 0 01), and the degree of reduction in the Tongxinluo group was significantly greater than that in the conventional group (P 0 05 or P 0 01) in the same period, and the decrease was more significant after **3 months (MMP-2:

281 74 21 15 vs. 363 17 14 19, MMP-9: 407 83 10 05 vs. 523 05 9 78, both p 0 01). The total effective rate of the Tongxinluo group was significantly higher than that of the conventional group (91 4 vs. 76 9, P 0 05).

ConclusionsTongxinluo capsule has the effect of stabilizing atheromatous plaque and alleviating clinical symptoms in patients, and its mechanism of action may be related to reducing the plasma level of MMP-2 9 in UAP patients.